8-K
filed January 21, 2026, 6:59 PM ET
CIK 0001865120
other material
confidence high
sentiment negative
materiality 0.70
Broad Capital Acquisition Corp. extends deadline to July 2027; 94,247 shares redeemed, only 6,969 remain.
Broad Capital Acquisition Corp
- Stockholders approved amendment extending business combination deadline to July 13, 2027 via up to 18 monthly extensions.
- Monthly extension fee reduced to $0.02 per share for non-redeemed shares starting Jan 13, 2026.
- 94,247 shares redeemed at ~$12.42/share, removing ~$1.17M from trust; only 6,969 shares remain outstanding.
- First extension deposit of $139.38 made to extend to February 13, 2026.
Machine-readable event card
- schema_version
- secwatch.filing_event.v1
- accession
- 0001493152-26-002965
- form_type
- 8-K
- ticker
- null
- cik
- 0001865120
- company_name
- Broad Capital Acquisition Corp
- filed_at
- 2026-01-21T23:59:59+00:00
- discovered_at
- 2026-05-14T18:02:36.603076+00:00
- generated_at
- 2026-05-16T09:21:08.875185+00:00
- sec_items
- ["2.03", "5.03", "5.07", "9.01"]
- event_type
- other_material
- sentiment
- negative
- materiality_score
- 0.7
- calibrated_materiality_score
- 0.7
- confidence
- high
- secwatch_canonical_url
- https://secwatch.observer/filing/0001493152-26-002965
- json_url
- https://secwatch.observer/filing/0001493152-26-002965.json
- markdown_url
- https://secwatch.observer/filing/0001493152-26-002965.md
- text_url
- https://secwatch.observer/filing/0001493152-26-002965.txt
- edgar_index_url
- https://www.sec.gov/Archives/edgar/data/1865120/000149315226002965/0001493152-26-002965-index.htm
- edgar_primary_document_url
- https://www.sec.gov/Archives/edgar/data/1865120/000149315226002965/form8-k.htm
- generated_by_model
- deepseek-v4-flash:cloud@v2
- review_status
- machine_generated
- human_reviewed
- false
- corrected
- false
- correction_note
- null
- correction_timestamp
- null
- superseded_by
- null
Comparable filings
LEGT
Legato Merger Corp. III shareholders approve extension to August 8, 2026 for Einride business combination
Legato Merger Corp. III
May 6, 2026, 7:59 PM ET
other_material
Items 2.03, 5.07, 5.03, 9.01
same fact type: governance_change
same SEC item: 2.03, 5.03, 5.07, 9.01
same event type: other_material
similar materiality
This filing
On January 9, 2025, the Company held a Special Meeting of Stockholders (the “ Meeting ”). At the Meeting, the Company’s stockholders approved an amendment to the Company’s Charter, as further amended on January 11, 2023, June 12, 2023, January 8, 2024 and January 13, 2025 (the “Charter Amendment Proposal ”), (a) to extend the date by which we have to consummate a business combination from January 13, 2026 (the “ Termination Date ”) by up to eighteen (18) one-month extensions to July 13, 2027 (the “ Extended Date ”) and (b) to decrease the monthly extension fee (the “ Monthly Extension Loan ”) to the Adjusted Monthly Extension Loan commencing on January 13, 2026.
Comparable filing
As previously disclosed, on November 12, 2025, Legato Merger Corp. III, a Cayman Islands exempted company (the “Company”), Einride AB, a limited liability company formed under the laws of Sweden (“Einride”), and Einride Cayman Sub Limited, a Cayman Islands exempted company and a direct, wholly-owned subsidiary of Einride (“Merger Sub”), entered into a Business Combination Agreement (“BCA”). Pursuant to the BCA, the Company will merge with and into Merger Sub, with Merger Sub surviving the merger (“Merger”). As a result of the Merger, Merger Sub will continue as a direct, wholly-owned subsidiary of Einride, with the shareholders of the Company becoming shareholders of Einride. On May 5, 2026, the Company held an extraordinary general meeting (the “Meeting”) to approve the following resolutions: ● to resolve as a special resolution, that the Company’s amended and restated memorandum and articles of association as adopted by special resolution dated February 5, 2024 with effect from Febru
Filing page
SEC filing
DCOM
Dime Commercial Bancshares name change effective; three executives amend employment agreements
Dime Community Bancshares, Inc. /NY/
June 1, 2026, 4:02 PM ET
other_material
Items 5.02, 5.03, 5.07, 9.01
same fact type: governance_change
same SEC item: 5.03, 5.07, 9.01
same event type: other_material
similar materiality
This filing
On January 9, 2025, the Company held a Special Meeting of Stockholders (the “ Meeting ”). At the Meeting, the Company’s stockholders approved an amendment to the Company’s Charter, as further amended on January 11, 2023, June 12, 2023, January 8, 2024 and January 13, 2025 (the “Charter Amendment Proposal ”), (a) to extend the date by which we have to consummate a business combination from January 13, 2026 (the “ Termination Date ”) by up to eighteen (18) one-month extensions to July 13, 2027 (the “ Extended Date ”) and (b) to decrease the monthly extension fee (the “ Monthly Extension Loan ”) to the Adjusted Monthly Extension Loan commencing on January 13, 2026.
Comparable filing
On May 28, 2026, the Company filed with the Department of State of the State of New York a Certificate of Amendment to Certificate of Incorporation to change our corporate name from Dime Community Bancshares, Inc. to Dime Commercial Bancshares, Inc., effective immediate.
Filing page
SEC filing
CVNA
Carvana stockholders approve 5-for-1 stock split, adopt new 2026 incentive plan
CARVANA CO.
May 6, 2026, 7:59 PM ET
other_material
Items 5.02, 5.03, 5.07, 9.01
same fact type: governance_change
same SEC item: 5.03, 5.07, 9.01
same event type: other_material
similar materiality
This filing
On January 9, 2025, the Company held a Special Meeting of Stockholders (the “ Meeting ”). At the Meeting, the Company’s stockholders approved an amendment to the Company’s Charter, as further amended on January 11, 2023, June 12, 2023, January 8, 2024 and January 13, 2025 (the “Charter Amendment Proposal ”), (a) to extend the date by which we have to consummate a business combination from January 13, 2026 (the “ Termination Date ”) by up to eighteen (18) one-month extensions to July 13, 2027 (the “ Extended Date ”) and (b) to decrease the monthly extension fee (the “ Monthly Extension Loan ”) to the Adjusted Monthly Extension Loan commencing on January 13, 2026.
Comparable filing
At the Annual Meeting, the Company's stockholders approved an amendment (the "Amendment") to the Company's Amended and Restated Certificate of Incorporation to effect a five-for-one forward stock split of the Company's Class A common stock and Class B common stock (the "Stock Split") and to proportionately increase the number of authorized shares of Class A common stock and Class B common stock (the "Authorized Share Increase").
Filing page
SEC filing
SLXN
Silexion shareholders approve 50M share increase, expanded equity plan, and 1-for-10 reverse split
Silexion Therapeutics Corp
May 5, 2026, 7:59 PM ET
other_material
Items 5.03, 5.07, 9.01
same fact type: governance_change
same SEC item: 5.03, 5.07, 9.01
same event type: other_material
similar materiality
This filing
On January 9, 2025, the Company held a Special Meeting of Stockholders (the “ Meeting ”). At the Meeting, the Company’s stockholders approved an amendment to the Company’s Charter, as further amended on January 11, 2023, June 12, 2023, January 8, 2024 and January 13, 2025 (the “Charter Amendment Proposal ”), (a) to extend the date by which we have to consummate a business combination from January 13, 2026 (the “ Termination Date ”) by up to eighteen (18) one-month extensions to July 13, 2027 (the “ Extended Date ”) and (b) to decrease the monthly extension fee (the “ Monthly Extension Loan ”) to the Adjusted Monthly Extension Loan commencing on January 13, 2026.
Comparable filing
At the extraordinary general meeting of Silexion Therapeutics Corp (the “ Company ”) originally held on April 28, 2026 and reconvened on May 5, 2026 (the “ Meeting ”), the shareholders of the Company duly approved a resolution serving as an effective amendment to paragraph 5 of the Company’s amended and restated memorandum of association (the “ Memorandum Amendment”) , which increased the Company’s authorized share capital, as described in Item 5.07 below.
Filing page
SEC filing
INSP
Inspire Medical shareholders approve declassification, 2.6M-share increase to equity plan
Inspire Medical Systems, Inc.
May 5, 2026, 7:59 PM ET
other_material
Items 5.02, 5.07, 5.03, 9.01
same fact type: governance_change
same SEC item: 5.03, 5.07, 9.01
same event type: other_material
similar materiality
This filing
On January 9, 2025, the Company held a Special Meeting of Stockholders (the “ Meeting ”). At the Meeting, the Company’s stockholders approved an amendment to the Company’s Charter, as further amended on January 11, 2023, June 12, 2023, January 8, 2024 and January 13, 2025 (the “Charter Amendment Proposal ”), (a) to extend the date by which we have to consummate a business combination from January 13, 2026 (the “ Termination Date ”) by up to eighteen (18) one-month extensions to July 13, 2027 (the “ Extended Date ”) and (b) to decrease the monthly extension fee (the “ Monthly Extension Loan ”) to the Adjusted Monthly Extension Loan commencing on January 13, 2026.
Comparable filing
On May 1, 2026, the Company filed a Certificate of Amendment to the Certificate of Incorporation (the “Certificate of Amendment”) with the Secretary of State of the State of Delaware, which became effective upon filing.
Filing page
SEC filing
AAWH
Ascend Wellness Holdings completes Class B conversion and annual meeting
Ascend Wellness Holdings, Inc.
May 5, 2026, 7:59 PM ET
other_material
Items 3.03, 5.03, 5.07, 9.01
same fact type: governance_change
same SEC item: 5.03, 5.07, 9.01
same event type: other_material
similar materiality
This filing
On January 9, 2025, the Company held a Special Meeting of Stockholders (the “ Meeting ”). At the Meeting, the Company’s stockholders approved an amendment to the Company’s Charter, as further amended on January 11, 2023, June 12, 2023, January 8, 2024 and January 13, 2025 (the “Charter Amendment Proposal ”), (a) to extend the date by which we have to consummate a business combination from January 13, 2026 (the “ Termination Date ”) by up to eighteen (18) one-month extensions to July 13, 2027 (the “ Extended Date ”) and (b) to decrease the monthly extension fee (the “ Monthly Extension Loan ”) to the Adjusted Monthly Extension Loan commencing on January 13, 2026.
Comparable filing
On May 5, 2026, the Company filed a Certificate of Retirement with the Secretary of State of the State of Delaware (the “Certificate of Retirement”) to effect the retirement of the 65,000 shares of Class B Common Stock that were issued but no longer outstanding following the Conversion. Pursuant to Section 243(b) of the DGCL, upon its effectiveness, the Certificate of Retirement had the effect of amending the Certificate of Incorporation to reduce the total number of authorized shares of common stock of the Company by 65,000, to 750,035,000, and to reduce the number of authorized shares of Class B Common Stock by 65,000, to 35,000.
Filing page
SEC filing
MRKR
Marker Therapeutics shareholders approve increase in authorized shares from 30M to 130M
Marker Therapeutics, Inc.
May 4, 2026, 7:59 PM ET
other_material
Items 5.03, 5.07, 9.01
same fact type: governance_change
same SEC item: 5.03, 5.07, 9.01
same event type: other_material
similar materiality
This filing
On January 9, 2025, the Company held a Special Meeting of Stockholders (the “ Meeting ”). At the Meeting, the Company’s stockholders approved an amendment to the Company’s Charter, as further amended on January 11, 2023, June 12, 2023, January 8, 2024 and January 13, 2025 (the “Charter Amendment Proposal ”), (a) to extend the date by which we have to consummate a business combination from January 13, 2026 (the “ Termination Date ”) by up to eighteen (18) one-month extensions to July 13, 2027 (the “ Extended Date ”) and (b) to decrease the monthly extension fee (the “ Monthly Extension Loan ”) to the Adjusted Monthly Extension Loan commencing on January 13, 2026.
Comparable filing
the Company’s stockholders approved an amendment to the Company’s Certificate of Incorporation, as amended, to increase the number of authorized shares of our Common Stock from 30,000,000 shares of Common Stock to 130,000,000 shares of Common Stock (the “ Charter Amendment ”).
Filing page
SEC filing
CWEN
Clearway Energy eliminates Class A stock; converts all shares to reduced-vote Class C
Clearway Energy, Inc.
May 1, 2026, 7:59 PM ET
other_material
Items 1.01, 3.03, 5.03, 5.07, 7.01, 9.01
same fact type: governance_change
same SEC item: 5.03, 5.07, 9.01
same event type: other_material
similar materiality
This filing
On January 9, 2025, the Company held a Special Meeting of Stockholders (the “ Meeting ”). At the Meeting, the Company’s stockholders approved an amendment to the Company’s Charter, as further amended on January 11, 2023, June 12, 2023, January 8, 2024 and January 13, 2025 (the “Charter Amendment Proposal ”), (a) to extend the date by which we have to consummate a business combination from January 13, 2026 (the “ Termination Date ”) by up to eighteen (18) one-month extensions to July 13, 2027 (the “ Extended Date ”) and (b) to decrease the monthly extension fee (the “ Monthly Extension Loan ”) to the Adjusted Monthly Extension Loan commencing on January 13, 2026.
Comparable filing
Following the Class A Conversion, on May 1, 2026, the Company filed with the Delaware Secretary of State a certificate of retirement pursuant to Section 243 of the DGCL (the “Certificate of Retirement”) to retire all shares of Class A common stock converted in the Class A Conversion, which also had the effect of amending the Amended Charter to (i) reduce the total number of authorized shares of Class A common stock from 34,613,853 to zero, (ii) reduce the total number of authorized shares of capital stock of the Company from 2,544,613,853 to 2,510,000,000 and (iii) eliminate from the Amended Charter all references to the Class A common stock (collectively, the “Class A Retirement”).
Filing page
SEC filing
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.